In perpetual awe of how 'simple' microbial organisms can perturb complex, multicellular eukaryotic organisms, Ami Bhatt has chosen to dedicate her research program to inspecting, characterizing and dissecting the microbe-human interface. Nowhere is the interaction between hosts and microbes more potentially impactful than in immunocompromised hosts and global settings where infectious and environmental exposures result in drastic and sometimes fatal health consequences.

Ami's group identifies problems and questions that arise in the course of routine clinical care. Often in collaboration with investigators at Stanford and beyond, the group applies modern genetic, molecular and computational techniques to seek answers to these questions, better understand host-microbe interactions and decipher how perturbation of these interactions may result in human disease phenotypes.

Professional Summary

Professional Education
  • Board Certification: American Board of Internal Medicine, Medical Oncology (2015)
  • Fellowship: Brigham and Women's Hospital Harvard Medical School (2014) MA
  • Residency: Brigham and Women's Hospital Harvard Medical School (2011) MA
  • Board Certification: American Board of Internal Medicine, Internal Medicine (2010)
  • Medical Education: University of California - San Francisco (2007) CA
  • Post-doctoral Fellowship, Broad Institute of Harvard and MIT (2014)
  • Hematology/Oncology Fellowship, Dana-Farber Cancer Institute, Harvard Medical School (2014)
  • Chief Residency, Brigham and Women's Hospital, Harvard Medical School (2011)
  • Residency, Brigham and Women's Hospital, Harvard Medical School (2009)
  • MD, University of California, San Francisco, Medicine (2007)
  • PhD, University of California, San Francisco, Biochemistry and Molecular Biology (2005)

Honors & Awards
  • AACR Clinical and Translational Fellowship, AACR (2012)
  • Alpha Omega Alpha, UCSF (2007)
  • Amy Strelzer Manasevit Scholar, National Marrow Donor Program (2013)
  • ASCO Young Investigator Award, ASCO (2013)
  • ASH Scholar Award, American Society of Hematology (2013)
  • Barr Innovative Basic Science Research Award, Dana-Farber Cancer Institute (2013)
  • Baxter Foundation Fellow, Baxter Foundation (2018)
  • Career Development Award (Fellow), Leukemia and Lymphoma Society (2013)
  • Chancellor's Fellowship, UCSF (2004)
  • Chen Award of Excellence, Human Genome Organisation (HUGO) (2018)
  • Damon Runyon Clinical Investigator Award, Damon Runyon Foundation (2016)
  • Elected Member, American Society for Clinical Investigation (ASCI) (2021)
  • Emerging Leader in Health and Medicine, National Academy of Medicine (2020)
  • Hall/Sewankambo Mid-Career Global Health Award, Consortiums of Universities for Global Health (2017)
  • McCormick and Gabilan Fellowship, Stanford University (2016)
  • Richard Fineberg Award for Excellence in Teaching, UCSF (2002)
  • Rosenkranz Prize for Healthcare Research in Developing Countries, Stanford University (2016)
  • Sloan Foundation Fellow, Sloan Foundation (2020)
  • V Scholar, V Foundation (2018)
  • World Cancer Young Leader Award, Union for International Cancer Control (2016)

Administrative Appointments
  • Director of Global Oncology, Center for Innovation in Global Health (2014 - Present)


Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Practice Locations

Hematologic Cancer Program Palo Alto, CA
Palo Alto, CA

875 Blake Wilbur Drive

Palo Alto , CA 94304

(650) 498-6000

Make An Appointment More Clinic Information » Getting Here »

Referring Physicians

  • Send referrals online
  • View referral status
  • Access medical records